BENDAMUSTINE HIKMA 2.5 mg/ml, powder for concentrate for infusion bottle
Active ingredients: Bendamustine hydrochloride, Bendamustine hydrochloride monohydrate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for concentrate for infusionbottleintraveineuse
Supply resumed
Package details
Original BDPM fields are shown in French.
- Official name
- BENDAMUSTINE HIKMA 2,5 mg/ml, poudre pour solution à diluer pour perfusion
- Pharmaceutical form
- poudre pour solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre jaune(brun) de 100 mg
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Oct 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63775634CIP73020824CIP133400930208243Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE BENDAMUSTINE MONOHYDRATÉpoudre | — | SA |
| CHLORHYDRATE DE BENDAMUSTINEpoudre | 25 mg · un flacon de 25 mg de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.